Cheol Lee J, Hung JY, Kim YC, Chang GC, Soo Yoo S, Yang SH, Davis KL, Nagar SP, Taylor A, Yong Lee S, Shih JY. Real-world treatment patterns in patients with EGFR mutation-positive NSCLC receiving a first line, first- or second-generation EGFR tyrosine kinase inhibitor in South Korea and Taiwan. Asian Pac J Cancer Bio. 2021 May 20;6(2). doi: 10.31557/APJCB.2021.6.2.123-132
Clienti D, Issel M, Wells R, Link (Anderson) S, Lich KH. System dynamics approaches and collective action for community health: an integrative review. Am J Community Psychol. 2019 Jun;63(3-4):527-45. doi: 10.1002/ajcp.12305